NCT00902200View on ClinicalTrials.gov

A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)

PHASE2CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Elevated Intraocular Pressure
Interventions
DRUG

AR-12286

See arms

DRUG

AR-12286 vehicle

See arms

Trial Locations (8)

28204

Mundorf Practice, Charlotte

34613

Hernando Eye Institute, Brooksville

40217

Taustine Eye Center, Louisville

57701

Black Hills Regional Eye Institute, Rapid City

78240

Medical Center Ophthalmology Associates, San Antonio

78731

Texan Eye, Austin

91105

Soilsh Practice, Pasadena

94954

Bacharach practice, Petaluma

Sponsors
All Listed Sponsors
lead

Aerie Pharmaceuticals

INDUSTRY

NCT00902200 - A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP) | Biotech Hunter | Biotech Hunter